Olivia C Ware
CIK 1663771 · Chief Commercial Officer · last filed 2026-04-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
17
Lifetime Open-Market Net
-$1.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Arcellx, Inc. (ACLX) Delisted | Director | 9,402 | $115.07 | $1.08M | -$1.16M | 7 | 2026-04-28 |
| CTNM | Director | — | $11.88 | — | $0 | 2 | 2025-06-26 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 0 | $3.65 | $0 | $0 | 7 | 2025-02-06 |
| LadRx Corp (CYTXW) Delisted | Chief Commercial Officer | — | — | — | $0 | 1 | 2016-01-14 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-05 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +3,534 | $0 | EDGAR |
| 2022-05-17 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-13 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-06 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,059 | $0 | EDGAR |
| 2021-05-07 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +674 | $0 | EDGAR |
| 2021-03-10 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,408 | $0 | EDGAR |
| 2016-01-14 | LadRx Corp (CYTXW) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.